Pre-Open Movers 07/25: (DBD) (NTGR) (MTH) Higher; (ALGN) (SAVE) (PTC) (more...)

July 25, 2019 9:16 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Today's Pre-Open Movers

Align Technology (NASDAQ: ALGN) 20.8% LOWER; reported Q2 EPS of $1.83, $0.32 better than the analyst estimate of $1.51. Revenue for the quarter came in at $600.7 million versus the consensus estimate of $599.38 million. Align Technology sees Q3 2019 EPS of $1.09-$1.16, versus the consensus of $1.44. Align Technology sees Q3 2019 revenue of $585-600 million, versus the consensus of $623.7 million.

Spirit Airlines (NYSE: SAVE) 14.6% LOWER; reported Q2 EPS of $1.69, $0.04 better than the analyst estimate of $1.65. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $1.01 billion.

Diebold Nixdorf (NYSE: DBD) 14.2% HIGHER; reported Q2 EPS of $0.06, $0.20 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.06 billion. Diebold Nixdorf sees FY2019 revenue of $4.5 billion, versus the consensus of $4.46 billion.

PTC (NASDAQ: PTC) 12.7% LOWER; reported Q3 EPS of $0.36, $0.02 better than the analyst estimate of $0.34. Revenue for the quarter came in at $322 million versus the consensus estimate of $320.73 million. PTC sees Q4 2019 EPS of $0.42-$0.52, versus the consensus of $0.50. PTC sees Q4 2019 revenue of $328-343 million, versus the consensus of $340 million. PTC sees FY2019 EPS of $1.43-$1.53, versus the consensus of $1.80. PTC sees FY2019 revenue of $1.249-1.264 billion, versus the consensus of $1.32 billion.

Tesla (NASDAQ: TSLA) 10.3% LOWER; reported Q2 EPS of ($1.12), $0.72 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $6.35 billion versus the consensus estimate of $6.41 billion.

Netgear, Inc. (NASDAQ: NTGR) 10% HIGHER; reported Q2 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $230.9 million versus the consensus estimate of $224.35 million. Netgear, Inc. sees Q3 2019 revenue of $265-280 million, versus the consensus of $267.11 million.

Cara Therapeutics, Inc. (Nasdaq: CARA) 8.7% LOWER; commenced an underwritten public offering of 5,000,000 shares of its common stock.

Anika Therapeutics (NASDAQ: ANIK) 7.9% HIGHER; reported Q2 EPS of $0.67, $0.28 better than the analyst estimate of $0.39. Revenue for the quarter came in at $30.4 million versus the consensus estimate of $27.5 million.

Meritage Homes Corporation (NYSE: MTH) 7% HIGHER; reported Q2 EPS of $1.31, $0.30 better than the analyst estimate of $1.01. Revenue for the quarter came in at $8.64 billion versus the consensus estimate of $804.08 million.

Tractor Supply (NASDAQ: TSCO) 6.6% LOWER; reported Q2 EPS of $1.80, in-line with the analyst estimate of $1.80. Revenue for the quarter came in at $2.35 billion versus the consensus estimate of $2.35 billion.

    ilinx (NASDAQ: XLNX) 6.5% LOWER; reported Q1 EPS of $0.94, in-line with the analyst estimate of $0.94. Revenue for the quarter came in at $850 million versus the consensus estimate of $847.37 million. Xilinx sees Q2 2020 revenue of $800-850 million, versus the consensus of $852.93 million. Tractor Supply sees FY2019 EPS of $4.65-$4.78, versus the consensus of $4.76. Tractor Supply sees FY2019 revenue of $8.4-8.46 billion, versus the consensus of $8.45 billion.

    Ford Motor (NYSE: F) 6.3% LOWER; reported Q2 EPS of $0.28, $0.04 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $35.76 billion versus the consensus estimate of $35.33 billion. Ford Motor sees FY2019 EPS of $1.20-$1.35, versus the consensus of $1.39.

    Citrix Systems (NASDAQ: CTXS) 5.5% LOWER; reported Q2 EPS of $1.21, $0.13 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $749 million versus the consensus estimate of $769.17 million. Citrix Systems sees Q3 2019 EPS of $1.15-$1.30, versus the consensus of $1.55. Citrix Systems sees Q3 2019 revenue of $700-720 million, versus the consensus of $763.2 million. Citrix Systems sees FY2019 EPS of $5.35-$5.60, versus the consensus of $6.03. Citrix Systems sees FY2019 revenue of $2.97-3.01 billion, versus the consensus of $3.09 billion.

    ServiceNow (NYSE: NOW) 4.6% LOWER; reported Q2 EPS of $0.71, $0.08 better than the analyst estimate of $0.63. Revenue for the quarter came in at $833.9 million versus the consensus estimate of $832.37 million. ServiceNow sees Q3 2019 revenue of $830-835 million, does not compare versus the consensus of $885.3 million. ServiceNow sees FY2019 revenue of $3.25-3.26 billion, does not compare versus the consensus of $3.45 billion.

    Masco Corp. (NYSE: MAS) 4.6% HIGHER; reported Q2 EPS of $0.88, $0.07 better than the analyst estimate of $0.81. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.34 billion.

    PayPal (NASDAQ: PYPL) 4.4% LOWER; reported Q2 EPS of $0.86, $0.12 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.31 billion versus the consensus estimate of $4.33 billion. PayPal sees Q3 2019 EPS of $0.69-$0.71, versus the consensus of $0.70. PayPal sees Q3 2019 revenue of $4.33-4.38 billion, versus the consensus of $4.44 billion. PayPal sees FY2019 EPS of $3.12-$3.17, versus the consensus of $3.03. PayPal sees FY2019 revenue of $17.6-17.8 billion, versus the consensus of $17.99 billion.

    Bristol-Myers Squibb Company (NYSE: BMY) 4.3% LOWER; announced that Part 2 of the Phase 3 CheckMate -227 trial did not meet the primary endpoint of overall survival (OS) with Opdivo® (nivolumab) plus chemotherapy versus chemotherapy in patients with first-line non-squamous non-small cell lung cancer (NSCLC), regardless of PD-L1 status (HR 0.86; 95% CI 0.69-1.08). The median OS for patients treated with Opdivo plus chemotherapy was 18.83 months vs. 15.57 months for chemotherapy, and the landmark one-year OS was 67.3 percent vs. 59.2 percent, respectively. In an exploratory analysis of patients with first-line squamous NSCLC, the median OS was 18.27 months for Opdivo plus chemotherapy vs. 11.96 months for chemotherapy (HR 0.69; 95% CI 0.50-0.97). No new safety signals were observed. The company will share complete findings from this trial at an upcoming medical meeting.

    3M Co. (NYSE: MMM) 4.2% HIGHER; reported Q2 EPS of $2.20, $0.15 better than the analyst estimate of $2.05. Revenue for the quarter came in at $8.17 billion versus the consensus estimate of $8.03 billion. 3M Co. sees FY2019 EPS of $9.25-$9.75, versus the consensus of $9.39.

    Hershey Foods (NYSE: HSY) 3.2% LOWER; reported Q2 EPS of $1.31, $0.14 better than the analyst estimate of $1.17. Revenue for the quarter came in at $1.77 billion versus the consensus estimate of $1.77 billion.

    Dish Network (NASDAQ: DISH) 2.4% LOWER; MoffettNathanson Downgraded from Neutral to Sell with a price target of $30.00.



      Serious News for Serious Traders! Try StreetInsider.com Premium Free!

      You May Also Be Interested In





      Related Categories

      Special Reports

      Related Entities

      Tesla, Pre-Open Losers, Pre-Open Winners, Pre Market Movers